Kenvue Inc (J4D): prezzo delle azioni e notizie

Simboli Simboli	Prezzo	Cambio	% di cambio	Tendenza	Chiusura prec.	Apri	Alto	Basso	Volume	Cap. mercato
SIXB Materials SIXB Materials	SIXB +0,25%	1.104,10	+2,73	+0,25%	—	1.101,37	1.103,63	1.105,31	1.091,41	—	—
SIXC Communications SIXC Communications	SIXC -1,50%	604,16	-9,19	-1,50%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE -0,09%	1.197,81	-1,02	-0,09%	—	1.198,83	1.199,68	1.199,75	1.182,41	—	—
SIXI Industrials SIXI Industrials	SIXI -0,88%	1.740,41	-15,54	-0,88%	—	1.755,95	1.754,06	1.756,03	1.734,69	—	—
SIXM Financials SIXM Financials	SIXM -0,64%	634,44	-4,07	-0,64%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR -0,31%	840,90	-2,62	-0,31%	—	843,52	843,35	846,40	837,93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0,38%	215,13	-0,82	-0,38%	—	215,95	215,95	216,84	215,06	—	—
SIXT Technology SIXT Technology	SIXT +2,86%	3.228,71	+89,80	+2,86%	—	3.138,91	3.189,30	3.230,85	3.174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	935,87	+1,50	+0,16%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV -1,37%	1.457,12	-20,31	-1,37%	—	1.477,43	1.474,12	1.474,12	1.451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,83%	2.399,84	+19,65	+0,83%	—	2.380,19	2.389,34	2.403,04	2.380,47	—	—

J4D:FRA

Kenvue Inc

14,68 €

+0,89%

(+0,13) 1G

24 apr, 22:00:00 GMT+2 · EUR

Tutti i simboli

YTD

MAX

	Simbolo	Prezzo	Cambio	% di cambio

Generazione degli approfondimenti principali per J4D in corso…

Apri

14,68 €

Alto

15,23 €

Basso

14,67 €

Cap. mercato

33,58 Mld

Vol. medio

89,00

Volume

210,00

Max 52 sett.

22,20 €

Min 52 sett.

11,83 €

N. di dipendenti

22K

Azioni correlate

Articoli giornalistici

Da fonti sul web

MarketBeat

1 giorno fa

Universal Beteiligungs und Servicegesellschaft mbH Has $17.15 Million Stock Holdings in Kenvue Inc. $KVUE

Simply Wall Street

1 giorno fa

A Look At Kenvue’s Valuation As Earnings Anticipation And CFO Transition Draw Investor Focus

Profilo

Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index. CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia

Informazioni su Kenvue Inc

CEO-

Dipendenti21,9K

Data di fondazione23 feb 2022

SedeSummit, New Jersey, Stati Uniti

SettorePersonal care products

Sito webkenvue.com

Tutti i valori in USD	mar 2025	giu 2025	set 2025	dic 2025
Fatturato	3,74 Mld	3,84 Mld	3,76 Mld	3,78 Mld
Costo dei beni venduti	1,57 Mld	1,57 Mld	1,53 Mld	1,63 Mld
Costo del venduto	1,57 Mld	1,57 Mld	1,53 Mld	1,63 Mld
Spese di ricerca e sviluppo	-	-	-	-
Spese totali per ricerca e sviluppo	-	-	-	-
Spese di vendita, generali e amministrative	1,54 Mld	1,50 Mld	1,51 Mld	1,51 Mld
Spese operative	1,55 Mld	1,51 Mld	1,51 Mld	1,48 Mld
Spese operative totali	3,12 Mld	3,08 Mld	3,04 Mld	3,11 Mld
Reddito operativo	625,00 Mln	760,00 Mln	726,00 Mln	674,00 Mln
Altri redditi non operativi	-	1,00 Mln	10,00 Mln	7,00 Mln
EBT inclusi elementi straordinari	458,00 Mln	588,00 Mln	526,00 Mln	427,00 Mln
EBT esclusi elementi straordinari	525,00 Mln	656,00 Mln	623,00 Mln	574,00 Mln
Spese per imposte sul reddito	136,00 Mln	168,00 Mln	128,00 Mln	97,00 Mln
Aliquota fiscale effettiva	29,69%	28,57%	24,33%	22,72%
Altre spese operative	13,00 Mln	5,00 Mln	1,00 Mln	-30,00 Mln
Risultato netto	322,00 Mln	420,00 Mln	398,00 Mln	330,00 Mln
Margine di profitto netto	8,61%	10,94%	10,57%	8,73%
Utili per azione	0,24	0,29	0,28	0,27
Interessi e reddito da investimento	13,00 Mln	13,00 Mln	14,00 Mln	11,00 Mln
Interesse passivo	-107,00 Mln	-107,00 Mln	-107,00 Mln	-109,00 Mln
Interessi passivi netti	-94,00 Mln	-94,00 Mln	-93,00 Mln	-98,00 Mln
Addebiti per ammortamento e svalutazione	-	-	-	-
EBITDA	761,00 Mln	902,00 Mln	867,00 Mln	713,00 Mln
Utile o perdita derivante dalla vendita di asset	-	-	-	-

I contenuti creati con l'AI potrebbero contenere errori. Scopri di più

AssistenzaInvia feedbackPrivacy Termini Disclaimer

Google Finanza

Ricerca